RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Menno de Jong appointed director of RIVM Centre for Infectious Disease Control Starting 1 May 2024, Professor Menno de Jong will take on the role of director of RIVM’s Centre for Infectious Disease Control (CIb) . He succeeds Jaap van Dissel, who is retiring in April 2024.
Strong interest among schools in incentive to promote healthy and sustainable eating Schools are highly interested in the promotional incentive of a programme teaching young children to eat healthy from a young age. The incentive is called ‘Let’s go outside for tasty food!’ or Lekker naar buiten! in Dutch. 2,273 schools applied for the funding over a three year period.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
BA.2.75 variant found in the Netherlands The BA.2.75 variant of the coronavirus SARS-CoV-2 has now also been found in the Netherlands. The variant was detected in a sample from 26 June 2022 taken in the region of Noordoost-Gelderland.
SARS-CoV-2 infections continue to rise Infections with the coronavirus SARS-CoV-2 in the Netherlands continued to rise this week. This increase can be seen in sewage surveillance and in the infections reported to the Municipal Public Health Services (GGDs).
Upward trend in infections continues Infections with the coronavirus SARS-CoV-2 in the Netherlands have increased for the third week in a row. The number of patients admitted to hospital nursing wards remained the same this week.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Even after COVID-19 crisis, social isolation continues Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.